Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Capital Employed (2023 - 2025)

Historic Return on Capital Employed for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q3 2025 value amounting to 0.48%.

  • Indivior Pharmaceuticals' Return on Capital Employed changed N/A to 0.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.48%, marking a year-over-year change of. This contributed to the annual value of 0.04% for FY2024, which is 2800.0% up from last year.
  • According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Return on Capital Employed is 0.48%.
  • Over the past 5 years, Indivior Pharmaceuticals' Return on Capital Employed peaked at 0.61% during Q2 2025, and registered a low of 0.01% during Q4 2023.
  • Its 3-year average for Return on Capital Employed is 0.25%, with a median of 0.09% in 2025.
  • Over the last 5 years, Indivior Pharmaceuticals' Return on Capital Employed had its largest YoY gain of 700bps in 2024, and its largest YoY loss of 700bps in 2024.
  • Quarter analysis of 3 years shows Indivior Pharmaceuticals' Return on Capital Employed stood at 0.01% in 2023, then surged by 730bps to 0.06% in 2024, then soared by 706bps to 0.48% in 2025.
  • Its Return on Capital Employed stands at 0.48% for Q3 2025, versus 0.61% for Q2 2025 and 0.09% for Q1 2025.